Anacor Pharma Raises $50 Million
Anacor Pharmaceuticals Inc., a Palo Alto, Calif.-based developer of topical therapeuticals, has raised $50 million in Series E funding. GlaxoSmithKline and Schering Corp. were joined by return backers Rho Capital Partners, Venrock Associates, Care Capital and Aberdare Ventures. The company raised around $37 million, and had filed for a $57.5 million IPO in August 2007.
7 January 2009•2 mins read
